Zydus Lifesciences Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 2,995.90 | 4,236 | 2,757.40 |
| Operating Expense | 2,285.20 | 1,858.60 | 2,144.70 |
| Net Profit | 339.60 | 1,722 | 296.50 |
| Net Profit Margin | 11.34% | 40.65% | 10.75% |
| Earning Per Share | 3.38 | 17.11 | 2.95 |
| EBIDTA | 712.30 | 2,435.10 | 638.60 |
| Effective Tax Rate | 16.56% | 18.79% | 13.35% |
Particulars
Jun 2026
Revenue2,995.90
Operating Expense2,285.20
Net Profit339.60
Net Profit Margin11.34
Earning Per Share3.38
EBIDTA712.30
Effective Tax Rate16.56
